Enclosed herewith audited financials for 31st march, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Veerhealth Care Ltd reported audited financial results for FY2026 ending March 31, 2026. Revenue from operations grew significantly to ₹3,248.45 lakhs from ₹1,686.66 lakhs in the previous year, representing approximately 93% year-on-year growth. Profit after tax (PAT) for the year stood at ₹54.40 lakhs compared to ₹39.15 lakhs in FY2025, a growth of about 39%. The company recorded an exceptional item of ₹31 lakhs (expense). Operating cash flow remained positive at ₹419.06 lakhs. EPS for the year was ₹0.27 per share. The Board did not recommend any dividend to conserve resources. Statutory auditors Jayesh R. Shah & Co. issued an unmodified (clean) audit opinion.
Strong top-line growth of ~93% is a positive signal, though PAT growth of ~39% lags revenue growth, suggesting margin pressure. The clean audit opinion removes uncertainty. No dividend may disappoint income-focused investors.